NBIX
NEUROCRINE BIOSC
Health Care·Biotechnology·UNITED STATES
$165.24
MCap $16.6B
as of 2026-06-09
Total
B1w
Fund
A1w
Quant
B1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-06-10
MIDOS SI
-0.19
Sentiment 70.8%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$165.24
Adaptive Mean
$166.13
-0.89 vs mean
Adaptive σ
2.35
MIDOS BB
$161.43 – $170.83
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-05-15
Composite Z
+0.64
ROE
22.5%
Z +0.63
Rev Gr
42.2%
Z +0.06
EPS Gr
41.5%
Z +0.08
OPM Gr
476.1%
Z +2.91
FCF Yld
5.2%
Z +0.38
EPS Surp
27.4%
Z +0.17
EPS 3mo Δ
7.5%
Z +0.26
Fwd P/E
13.00
Z —
PEGY
0.31
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-06-10
Q3M
11.78
Q6M
0.61
Q12M
2.47
MA 30/100
1.105
Bullish (MA30 > MA100)
α (Jensen)
0.7561
β (12M)
0.79
σ (12M)
0.312
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
94%
Q Percentile
65%
Divergence
+29.3
Tier
RELOAD — ACT
Fundamentals ahead of momentum.
Kirkpatrick RS & Persistence
RS
0.2
RS Pctl
52%
RS Decile
D6
Persistence
1w
at grade B
Options / OI Analysis
No options or Williams data available for this ticker.